Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHMOLL, Hans-Joachim")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 88

  • Page / 4
Export

Selection :

  • and

Special Issue: High-dose ChemotherapySCHMOLL, Hans-Joachim.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, issn 1040-8428, 142 p.Serial Issue

High-dose chemotherapy in adult soft tissue sarcomaREICHARDT, Peter.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 157-167, issn 1040-8428Article

The role of high-dose chemotherapy in the treatment of non-small cell lung cancerFETSCHER, Sebastian.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 151-156, issn 1040-8428Article

The future development of bevacizumab in colorectal cancerDIAZ-RUBIO, Eduardo; SCHMOLL, Hans-Joachim.Oncology. 2005, Vol 69, pp 34-45, issn 0030-2414, 12 p., SUP3Article

Tumor cell contamination in re-infused stem cell autografts : Does it have clinical significance?SHIMONI, Avichai; KÖRBLING, Martin.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 241-250, issn 1040-8428Article

Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatmentJORDAN, Karin; KASPER, Christoph; SCHMOLL, Hans-Joachim et al.European journal of cancer (1990). 2005, Vol 41, Num 2, pp 199-205, issn 0959-8049, 7 p.Article

VEGF as a key mediator of angiogenesis in cancerCARMELIET, Peter.Oncology. 2005, Vol 69, pp 4-10, issn 0030-2414, 7 p., SUP3Article

High-dose chemotherapy in advanced breast cancerVIENS, Patrice; MARANINCHI, Dominique.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 141-149, issn 1040-8428Article

High-dose chemotherapy in soft tissue sarcoma in childrenATRA, Ayad; PINKERTON, Ross.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 191-196, issn 1040-8428Article

High-dose chemotherapy and autologous bone marrow transplantation in diffuse intermediate- and high-grade non-Hodgkin lymphomaPHILIP, Thierry; BIRON, Pierre.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 213-223, issn 1040-8428Article

High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT)BURDACH, S; JÜRGENS, H.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 169-189, issn 1040-8428Article

Adjuvant Therapy for Early Colon Cancer: Current StatusSTEIN, Alexander; HIEMER, Sonja; SCHMOLL, Hans-Joachim et al.Drugs (Basel). 2011, Vol 71, Num 17, pp 2257-2275, issn 0012-6667, 19 p.Article

Critical role of anti-angiogenesis and VEGF inhibition in colorectal cancerDIAZ-RUBIO, Eduardo; SCHMOLL, Hans-Joachim.Oncology. 2005, Vol 69, issn 0030-2414, 59 p., SUP3Serial Issue

Economic aspects of high-dose chemotherapy: a clinician's perspective reviewCETTO, Gian Luigi; MOLINO, Annamaria.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 251-267, issn 1040-8428Article

VEGF as a therapeutic target in cancerFERRARA, Napoleone.Oncology. 2005, Vol 69, pp 11-16, issn 0030-2414, 6 p., SUP3Article

Protective effect of oral phosphatidylcholine on radiation-induced release of intestinal peptidases in ratsFITTKAU, Marina; GERLACH, Reinhard; SCHMOLL, Hans-Joachim et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 7, pp 444-448, issn 0171-5216Article

Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinomaSAAD, Everardo D; ABBRUZZESE, James L.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 205-211, issn 1040-8428Article

Human hematopoietic growth factors : Old lessons and new perspectivesDEMPKE, Wolfram; VON POBLOZKI, Almut; GROTHEY, Axel et al.Anticancer research. 2000, Vol 20, Num 6D, pp 5155-5164, issn 0250-7005Article

Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancerHURWITZ, Herbert; KABBINAVAR, Fairooz.Oncology. 2005, Vol 69, pp 17-24, issn 0030-2414, 8 p., SUP3Article

Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancerLORCH, Jochen H; THOMAS, Tarita O; SCHMOLL, Hans-Joachim et al.Cancer research (Baltimore). 2007, Vol 67, Num 2, pp 727-734, issn 0008-5472, 8 p.Article

Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in ratsFITTKAU, Marina; VOIGT, Wieland; HOLZHAUSEN, Hans-Jürgen et al.Journal of cancer research and clinical oncology. 2004, Vol 130, Num 7, pp 388-394, issn 0171-5216, 7 p.Article

Cyclooxygenase-2: a novel target for cancer chemotherapy?DEMPKE, Wolfram; RIE, Christoph; GROTHEY, Axel et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 7, pp 411-417, issn 0171-5216Article

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatmentGROTHEY, Axel; SARGENT, Daniel; GOLDBERG, Richard M et al.Journal of clinical oncology. 2004, Vol 22, Num 7, pp 1209-1214, issn 0732-183X, 6 p.Article

High-dose therapy for indolent lymphomaMOUNIER, Nicolas; SOCIE, Gérard; GISSELBRECHT, Christian et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 225-239, issn 1040-8428Article

A low dose of ionizing radiation increases luminal release of intestinal peptidases in ratsFITTKAU, Marina; GROTHEY, Axel; GERLACH, Reinhard et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 2, pp 96-100, issn 0171-5216Article

  • Page / 4